Zydus Receives US FDA Approval for ZITUVIO™ to Treat Adult Patients with Type 2 Diabetes Mellitus

Zydus Lifesciences Limited announced that the US FDA approved its New Drug Application for ZITUVIO™, Sitagliptin, tablets, 25 mg, 50 mg, and 100 mg. The approval of ZITUVIO™ was based on research, development, regulatory, and manufacturing work performed by Zydus teams.